FLDDW
Fold Holdings, Inc. WarrantNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
0.36
52W High
$0.83
52W Low
$0.08
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
-164.60%
Forward P/E
—
PEG Ratio
—
About Fold Holdings, Inc. Warrant
Fold Holdings, Inc. Warrant is a biotechnology enterprise dedicated to pioneering therapeutic solutions for rare genetic disorders. The company is advancing a strong pipeline of proprietary drug candidates through clinical development, highlighting its focus on addressing critical unmet medical needs in the healthcare landscape. With a strategic emphasis on innovation, Fold Holdings represents a compelling opportunity for institutional investors seeking growth and diversification within the biopharmaceutical industry, particularly as it aims to transform treatment paradigms for underserved patient populations.
Fundamentals
| Revenue (TTM) | $30.30M |
| Gross Profit (TTM) | $-13.26M |
| EBITDA | $-26.89M |
| Operating Margin | -167.00% |
| Return on Equity | -92.20% |
| Return on Assets | -15.00% |
| Revenue/Share (TTM) | $0.63 |
| Book Value | $0.72 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 1622.00% |
| Quarterly Revenue Growth (YoY) | -21.10% |
| Shares Outstanding | 0 |
| Float | $6.20M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
97.74%
HV 20-Day
165.43%
HV 30-Day
174.54%
HV 60-Day
161.81%
HV Rank
—
Volatility is currently contracting
Data last updated: 7/9/2026